Trofosfamide (Synonyms: NSC 109723) |
Catalog No.GC18367 |
Le trofosfamide est un dérivé d'oxazaphosphorine biodisponible par voie orale avec une activité antinéoplasique.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 22089-22-1
Sample solution is provided at 25 µL, 10mM.
Trofosfamide is an orally bioavailable oxazaphosphorine derivative with antineoplastic activity[1].
References:
[1]. Witte HM, et al. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2019 Jan;145(1):129-136.
[2]. Görn M, et al. A pilot study of docetaxel and trofosfamide as second-line 'metronomic' chemotherapy in the treatment of metastatic non-small cell lung cancer (NSCLC). Onkologie. 2008 Apr;31(4):185-9.
Average Rating: 5
(Based on Reviews and 12 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *